| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |